Details of the Drug

General Information of Drug (ID: DMF1ZNU)

• Drug Name: DDG-39
• Synonyms: FddC; Ro-31-6840; 1-(2',3'-Dideoxy-2'-fluoro-beta-D-arabinofuranosyl)cytosine; 2'betaFddC; 4-Amino-1-(2,3-dideoxy-2-fluoro-beta-D-threo-pentofuranosyl)-2(1H)-pyrimidinone

Indication

Disease Entry	ICD 11	Status	REF
Acquired immune deficiency syndrome	1C62.3	Terminated	[1]

• Drug Type: Small molecular drug
• Chemical Identifiers:
  Formula: C9H12FN3O3
  Canonical SMILES: C1C(OC(C1F)N2C=CC(=NC2=O)N)CO
  InChI: InChI=1S/C9H12FN3O3/c10-6-3-5(4-14)16-8(6)13-2-1-7(11)12-9(13)15/h1-2,5-6,8,14H,3-4H2,(H2,11,12,15)/t5-,6-,8+/m0/s1
  InChIKey: LTDCCBLBAQXNKP-VMHSAVOQSA-N
• Cross-matching ID:
  PubChem CID: 64990
  CAS Number: 119555-47-4
  TTD ID: D07ULS
• Drug ADMET Endpoint Profile (DAE)NEW: Click to Jump to the Detailed DAE Information of This Drug

References

• [1] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001933)